Taysha gene therapies announces fast track designation granted by u.s. fda for tsha-102 in rett syndrome

Fast track designation (ftd) is designed to accelerate the development and expedite the review of therapies with potential to address unmet medical needs for a serious or life-threatening condition
TSHA Ratings Summary
TSHA Quant Ranking